Published in Proc Natl Acad Sci U S A on May 13, 2013
Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels. Front Physiol (2017) 0.75
Reply to Harris et al.: Differential impacts of omega-3 fatty acids and their derivatives on blood pressure. Proc Natl Acad Sci U S A (2013) 0.75
Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels. Proc Natl Acad Sci U S A (2013) 1.91
Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med (2008) 1.78
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Universal definition of myocardial infarction. Circulation (2007) 11.69
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med (2002) 9.74
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation (2002) 9.02
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care (2004) 5.39
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res (2004) 4.00
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 3.42
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Death by parenteral nutrition. Intensive Care Med (2003) 3.25
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Omega-3 fatty acids for cardioprotection. Mayo Clin Proc (2008) 2.65
The paradoxical effect of obesity on outcome in critically ill patients. Crit Care Med (2006) 2.25
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation (2002) 2.18
Protocols: help for improvement but beware of regression to the mean and mediocrity. Intensive Care Med (2015) 2.15
n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr (2006) 2.01
Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J (2008) 1.83
Pulmonary complications of novel antineoplastic agents for solid tumors. Chest (2008) 1.80
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA (2009) 1.79
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther (2006) 1.77
Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol (2003) 1.76
Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA (2010) 1.71
Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest (2005) 1.70
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc Res (2005) 1.64
Quantitative diagnosis of diffuse alveolar damage using extravascular lung water. Crit Care Med (2013) 1.64
Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res (2008) 1.62
Multidisciplinary family meetings in the ICU facilitate end-of-life decision making. Am J Hosp Palliat Care (2009) 1.61
Complete myocardial revascularization: between myth and reality. Eur Heart J (2005) 1.55
Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies. JACC Cardiovasc Interv (2013) 1.54
Association between time of admission to the ICU and mortality: a systematic review and metaanalysis. Chest (2010) 1.53
Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol (2006) 1.53
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis (2007) 1.52
Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med (2014) 1.52
Stress hyperglycemia: an essential survival response! Crit Care (2013) 1.49
Distal embolization during primary angioplasty: histopathologic features and predictability. Am Heart J (2005) 1.47
Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr (2010) 1.47
Death by TPN... the final chapter? Crit Care Med (2008) 1.46
The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. Int J Cardiol (2013) 1.45
Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study. Ann Behav Med (2012) 1.44
The role of head computer tomographic scans on the management of MICU patients with neurological dysfunction. J Intensive Care Med (2009) 1.44
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res (2002) 1.44
Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res (2009) 1.42
The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids (2005) 1.42
Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes (2004) 1.41
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. Am Heart J (2004) 1.41
A 53-year-old man with fever, clubbing, hemoptysis, and rapid onset of respiratory failure. Chest (2007) 1.41
Unraveling the mystery of adrenal failure in the critically ill. Crit Care Med (2004) 1.41
You are what you eat applies to fish, too. J Am Diet Assoc (2008) 1.39
What's new with hypertensive crises? Intensive Care Med (2014) 1.39
Counterpoint: Are the best patient outcomes achieved when ICU bundles are rigorously adhered to? No. Chest (2013) 1.39
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol (2003) 1.39
Acupuncture for asthma: fact or fiction? Chest (2002) 1.37
ICU care at the end of life. Chest (2004) 1.36
Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J (2004) 1.34
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J (2011) 1.34
Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res (2006) 1.34
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A (2006) 1.32
Recommendations for the management of patients after heart valve surgery. Eur Heart J (2005) 1.29
A 64-year-old male with fever and persistent lung infiltrate. Respir Care (2009) 1.28
At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol (2005) 1.27
Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys (2012) 1.24
Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol (2009) 1.23
Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol (2009) 1.23
Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc (2013) 1.23
Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J (2011) 1.23
Stress hyperglycemia: an essential survival response! Crit Care Med (2013) 1.22
Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids (2008) 1.22
Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis (2008) 1.22
Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts. Circulation (2011) 1.21
Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part I: General Ultrasonography. Crit Care Med (2015) 1.21
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol (2006) 1.20
Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther (2014) 1.20
Fish oil -- how does it reduce plasma triglycerides? Biochim Biophys Acta (2011) 1.20
Clinical review: the management of hypertensive crises. Crit Care (2003) 1.19
Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol (2006) 1.16
Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes (2003) 1.15
Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes. Vascul Pharmacol (2011) 1.14
Perioperative hypertension management. Vasc Health Risk Manag (2008) 1.13
Determinants of Blood Cell Omega-3 Fatty Acid Content. Open Biomark J (2008) 1.13
Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study. Circ Cardiovasc Qual Outcomes (2010) 1.13
Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis (2003) 1.12
Non-coronary atherosclerosis. Eur Heart J (2014) 1.11